Evanthia Zampeli
Overview
Explore the profile of Evanthia Zampeli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papathanasiou E, Kokkotis G, Axiaris G, Bellou G, Chalakatevaki K, Christidou A, et al.
Eur J Gastroenterol Hepatol
. 2024 Sep;
37(2):154-160.
PMID: 39324945
Background: Inflammatory bowel disease (IBD) commonly affects patients of reproductive age. The effect of disease activity on the outcome of pregnancy and its impact on neonatal health are areas of...
2.
Markopoulos P, Karmiris K, Dimas I, Voudoukis E, Siakavellas S, Axiaris G, et al.
Inflamm Bowel Dis
. 2024 Aug;
PMID: 39102755
Background: Patients with inflammatory bowel disease (IBD) exhibit an increased risk for acquiring hepatitis B virus (HBV), thus they should be vaccinated preferably, if not already infected or immunized. We...
3.
Krikelis M, Papathanasiou E, Leonidakis G, Pardalis P, Michopoulos S, Zampeli E
Mediterr J Rheumatol
. 2024 May;
35(1):150-155.
PMID: 38736963
Introduction: Aberrant activation of the IL-23/IL-17 axis leads to inflammatory phenotypes with overlapping clinical characteristics. Inhibition of IL-17 has mostly an anti-inflammatory effect, but sporadic cases of new-onset IBD have...
4.
Ioannou A, Axiaris G, Baxevanis P, Papathanasiou E, Tzakri M, Koumentakis C, et al.
Ann Gastroenterol
. 2024 Mar;
37(2):172-178.
PMID: 38481779
Background: Bowel cleansing is an important factor for the quality of colonoscopy. We aimed to evaluate the efficacy of split-dose oral sulfate salts on bowel preparation and to determine parameters...
5.
Axiaris G, Ioannou A, Papoutsaki M, Marinos L, Liontos M, Michopoulos S, et al.
F1000Res
. 2023 Oct;
11:424.
PMID: 37867623
The cornerstone of inflammatory bowel disease (IBD) treatment is immunomodulators. IBD patients are at increased risk of intestinal and extraintestinal malignancy. Ustekinumab is a fully humanized monoclonal anti-IL12/23 antibody with...
6.
Katsoula A, Axiaris G, Mpitouli A, Palatianou M, Christidou A, Dimitriadis N, et al.
J Clin Med
. 2023 Apr;
12(8).
PMID: 37109360
Background: The Inflammatory Bowel Disease-Disk (IBD-Disk) is a physician-administered tool that evaluates the functional status of patients with Inflammatory Bowel Disease (IBD). The aim of our study was to validate...
7.
Kokkotis G, Zampeli E, Tzouvala M, Giotis I, Orfanos P, Benetou V, et al.
Eur J Gastroenterol Hepatol
. 2023 Feb;
35(4):371-375.
PMID: 36827531
Objectives: Vedolizumab is a mAb used for the treatment of moderate to severe ulcerative colitis and Crohn's disease. There is evidence that administration of vedolizumab has been associated with either...
8.
Mantzaris G, Zeglinas C, Theodoropoulou A, Koutroubakis I, Orfanoudaki E, Katsanos K, et al.
Crohns Colitis 360
. 2023 Feb;
3(4):otab064.
PMID: 36777275
Background: Data on the effectiveness of anti-tumor necrosis factor medications in patients with Crohn's disease (CD) with poor prognostic factors (PPFs) are scarce. This study aimed to generate real-world evidence...
9.
Bamias G, Zampeli E, Domenech E
Expert Rev Gastroenterol Hepatol
. 2022 Jul;
16(8):721-735.
PMID: 35833363
Introduction: Inflammatory bowel disease (IBD) is a chronic immune-mediated disease of the gastrointestinal tract comprising Crohn's disease (CD) and ulcerative colitis (UC). While any part of the digestive tract can...
10.
Zacharopoulou E, Orfanoudaki E, Tzouvala M, Tribonias G, Kokkotis G, Kitsou V, et al.
Inflamm Bowel Dis
. 2022 Apr;
29(2):228-237.
PMID: 35394529
Background: Four EMA-approved vaccines against SARS-CoV-2 are currently available. Data regarding antibody responses to initial vaccination regimens in patients with inflammatory bowel diseases (IBD) are limited. Methods: We conducted a...